InvestorsHub Logo
Followers 30
Posts 1494
Boards Moderated 1
Alias Born 10/15/2014

Re: None

Wednesday, 03/31/2021 9:47:06 AM

Wednesday, March 31, 2021 9:47:06 AM

Post# of 42483
HGEN doesn't even need COVID. HGEN could be chosen to be used with any cancer treatment where the Cytokine Storm is a concern making it worth way over $25 Billion on that alone in my opinion, that is over $500 a share without COVID. All in my opinion

HGEN is gold.
Its gold for shareholders.
Its gold for cancer patients.
Its gold for COVID patients.


All in my opinion
GLTA
-Swami